Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 August 2019 | Story Xolisa Mnukwa | Photo Xolisa Mnukwa
Student Toolkit
The First Edition of the UFS Student Toolkit is now available on Blackboard.

Download the toolkit here

A common question first-time entering first-year students often ask themselves when they come to university, is: ‘How will I deal with the pressure?’

The University of the Free State (UFS) Department of Student Counselling and Development (SCD) – with the vision to promote, enable, and optimise students’ self-direction – has launched the first edition of the Student Toolkit on Friday, 23 August 2019.

The toolkit, which is now available on Blackboard, is intended to assist students in dealing and coping with challenges they face in their personal lives during their period of study at the UFS.

Students will be exposed to a variety of topics, pressing issues, and phenomena that they will encounter on a daily basis in their lives, such as academic and personal challenges, time management, procrastination, goal setting, anxiety, effective studying, stress management, mindful meditation, self-love, loneliness, relationships, sexual orientation, family frustrations, overthinking, death, and suicide. 

Present at the launch was the UFS Vice-Rector: Institutional Change, Student Affairs, and Community Engagement, Prof Puleng LenkaBula; the UFS Dean of Student Affairs, Mr Pura Mgolombane; the UFS Director for Student Counselling and Development, Melissa Barnaschone; Counselling Psychologist and compiler of the UFS Student Toolkit: Lize van den Bergh.

In addition, BCom Marketing honours student and poet, Thuthukani Ndlovu, Chief Executive Officer and founder of Next Chapter, Tshepang Mahlatsi, three students who have benefitted from SDC services, delegates from the department, and other affiliated students were all in attendance. 

For more information about the Student Toolkit, contact the Department of Student Counselling and Development at scd@ufs.ac.za or call +27 51 401 2853.


News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept